GVV-27980-76950 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-26
Dose 1 — Pfizer-BioNTech
2021-04-16
Dose 2 — Pfizer-BioNTech
2021-04-21
Registered in v-safe
2021-04-21
Survey response — days 1–6 daily, dose 2
MedDRA: Lip swelling, Ocular hyperaemia, Peripheral swelling — Feeling: Poor · Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities

Free text: Swollen hands, feet, and lips. Red eyes.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-22
Survey response — days 1–6 daily, dose 2
MedDRA: Peripheral swelling, Swelling face — Feeling: Poor · Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities

Free text: Swelling of the Hands, feet and face.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-25
Health check-in — day 7, dose 2
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-05-02
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-05-14
Survey response — day 28, dose 2
MedDRA: Balance disorder, Discomfort — Feeling: Fair

Free text: Feeling of heaviness and unbalanced.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-30
Survey response — day 42, dose 2
MedDRA: Hypertension — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Hypertension

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-30
Report sent to call center — day 42, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-07-16
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-10-15
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-04-16
Survey response — 12 months, dose 2
MedDRA: Caesarean section, Pre-eclampsia — Feeling: Fair · Get care from a doctor or other healthcare professional · Hospitalization

Free text: Symptoms: Pre clampsia · Healthcare visit (other): C section

MedDRA releases: 2024-11 · check-in free text available
2022-04-16
Report sent to call center — 12 months, dose 2
Get care from a doctor or other healthcare professional

Hospitalization · 1 call case(s)
2022-04-20
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-26	Pfizer-BioNTech
2	2021-04-16	Pfizer-BioNTech

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 7 — days 1–6 daily, dose 2

2021-04-21

Systemic reaction (other): Swollen hands, feet, and lips. Red eyes.

2021-04-22

Systemic reaction (other): Swelling of the Hands, feet and face.

Release 8 — day 28, dose 2

2021-05-14

Symptoms: Feeling of heaviness and unbalanced.

Release 8 — day 42, dose 2

2021-05-30

Symptoms: Hypertension

Release 11 — 12 months, dose 2

2022-04-16

Symptoms: Pre clampsia

Healthcare visit (other): C section

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Caesarean section	·	·	✓
SD	Balance disorder	✓	✓	✓
SD	Discomfort	✓	✓	✓
SD	Hypertension	✓	✓	✓
SD	Pre-eclampsia	·	·	✓
SRO	Lip swelling	✓	✓	✓
SRO	Ocular hyperaemia	✓	✓	✓
SRO	Peripheral swelling	✓	✓	✓
SRO	Swelling face	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release